Share this article on:

Effects of methylprednisolone on the duration of rocuronium-induced neuromuscular block: A randomized double-blind trial

Geng, Weilian MD; Nie, Yuyan MD; Huang, Shaoqiang MD*

Section Editor(s): Chu., Danny

doi: 10.1097/MD.0000000000007947
Research Article: Clinical Trial/Experimental Study

Background: We aim to investigate whether intraoperative use of methylprednisolone could affect the duration of rocuronium-induced neuromuscular blockade.

Methods: A double blind, randomized, placebo-controlled trial was conducted. A total of 136 patients underwent gynecologic laparoscopic surgery were randomly divided into 3 groups: pregroup, receiving intravenous injection of methylprednisolone (40 mg) 30 minutes before induction of anesthesia; postgroup, receiving intravenous injection of methylprednisolone (40 mg) immediately after induction of anesthesia and intubation; and control group, receiving intravenous injection of normal saline. Patients were intravenously administrated with rocuronium 0.6 mg/kg, and changes in adductor policies evoked twitch responses were measured by ulnar nerve stimulator.

Results: We found that all patients achieved maximum blockade effects, and there was no difference in onset time among the 2 groups. For time required to achieve train-of-four ratio (TOFR) 90%, pregroup (64.50 ± 10.52 minutes) and postgroup (65.29 ± 11.64 minutes) were significantly shorter than that of the control group (71.04 ± 10.55 minutes, P = .027), whereas clinical duration and total duration were significantly shorter in the 2 groups received methylprednisolone than the control group. However, there was no significant difference between the 2 treatment groups either in clinical duration and total duration of muscle relaxants, or time required to achieve TOFR 90%. No significant difference was found in recovery index among the 3 groups.

Conclusion: Our findings suggest that a single intravenous injection of methylprednisolone, no matter preoperatively or intraoperatively, could shorten the duration of rocuronium-induced neuromuscular blockade.

Department of Anesthesia, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Correspondence: Shaoqiang Huang, Department of Anesthesia, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China (e-mail:

Abbreviations: PONV = postoperative nausea and vomiting, TOF = train-of-four, TOFR = TOF ratio.

The authors have no funding and conflicts of interest to disclose.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.

Received April 16, 2017

Received in revised form August 4, 2017

Accepted August 8, 2017

Back to Top | Article Outline

1 Introduction

Corticosteroid could affect the effect of muscle relaxant. Some vitro studies found that betamethasone attenuated the effects of nondepolarizing muscle relaxants, and this action was similar to other various nondepolarizing muscle relaxants.[1] Soltesz et al[2] had shown that for patients with long-term use of prednisolone, rocuronium had a prolonged onset time of muscle relaxation while the duration of action was shortened. Case reports suggested that patients with long-term oral prednisone had complete resistance to a maximal dose of rocuronium.[3] However, currently, information about the effects of single relevant perioperative corticosteroids on muscle relaxation is relatively limited. One clinical study observed that dexamethasone only shorten the duration of rocuronium-induced neuromuscular blockade if dexamethasone was administered 2 to 3 hours before surgery; however, intraoperative use of dexamethasone had no similar effects.[4]

In our clinic, we always use methylprednisolone intraoperatively for mild to moderate allergy or asthma because of its more rapid onset time than dexamethasone. On the other hand, methylprednisolone is a common perioperative corticosteroid that can be used to prevent postoperative nausea and vomiting (PONV),[5,6] relieve postoperative pain,[7–9] improve lung function,[10–12] attenuate laryngeal edema after extubation and airway obstruction,[13,14] suppress perioperative inflammatory response,[15–20] reduce perioperative mortality, shorten extubation time and length of stay, and increase comfortable feeling in patients.[21]

The purpose we design this study is not only to know whether single use of methylprednisolone affect muscle relaxant, but also the affection between methylprednisolone which was administrated after anesthesia intubation and muscle relaxant during the surgery.

Back to Top | Article Outline

2 Materials and methods

The present investigation was a randomized and double-blinded study, approved by the ethics committee of Obstetrics and Gynecology Hospital, Fudan University (Shanghai, China). The study was successfully registered in Chinese Clinical Trials Registry (registration number: ChiCTR-IOR-15005906). After written informed consent was obtained, 136 patients underwent general anesthesia for laparoscopic gynecological surgery in Obstetrics and Gynecology Hospital, Fudan University, from March to September 2015, were enrolled. Inclusion criteria included aged between 18 and 60 years old, American Society of Anesthesiologists physical status diagnosed as I or II, and estimated operation time >1 hour. Exclusion criteria included neuromuscular diseases, laboratory abnormalities in electrolytes, liver and kidney dysfunction, allergy to muscle relaxants, medication history of glucocorticoids, anticholinergics, magnesium and aminoglycoside antibiotics within the past 1 week,[22–25] and pregnancy. Patients were randomly divided into 3 groups using computer-based random number table: pregroup, receiving methylprednisolone 40 mg half an hour before induction of anesthesia; postgroup, receiving methylprednisolone 40 mg after induction of anesthesia and intubation; and control group, receiving normal saline.

Patients were fasted routinely, with no additional premedication provided. After entered into the operation room, patients were laid in a supine position; afterwards, routine monitoring was conducted, including noninvasive blood pressure, electrocardiogram, finger pulse oxygen saturation, and bispectral index (Aspect Medical Systems, Norwood, MA). Upper extremity venous was opened by 18G trocar, and Ringer lactate was infused at a rate of 8 mL/kg/hour. Patients were administered according to their numbers of administration. For all patients, anesthesia was induced by intravenous infusion of propofol 2.5 mg/kg, sufentanil 0.5 μg/kg, and rocuronium 0.6 mg/kg (SFDAH20093186; Xianju Medicine Ltd., Zhejiang, China, batch No.120807), followed by tracheal intubation. After successful intubation, mechanical ventilation was performed in a volume controlled ventilation mode; tidal volume was set at 6 to 8 mL/kg, and respiratory rate was at 10 to 12/minute. Breath parameters were adjusted based on end-tidal carbon dioxide partial pressure (PetCO2) to keep PetCO2 at 35 to 45 mm Hg. Anesthesia was maintained with propofol at a rate of 6 to 12 mg/kg/hour and remifentanil at a rate of 0.2 to 0.25 μg/kg/minute to keep a bispectral index value in the range of 40 to 60. Oesophageal temperature was maintained at 36 to 37 °C, otherwise heated intravenous fluids and warm blankets will be provided if necessary. During the surgery, if patients showed body movement or surgeons required extra muscle relaxants, rocuronium 10 to 20 mg will be added; however, those patients were then withdrew from the present study. Before the end of the surgery, ramosetron 0.3 mg was administered intravenously to prevent PONV and tramadol 100 mg was provided for analgesia. In addition, phenylephrine 100 μg will be provided if the mean arterial pressure was below 90 mm Hg or decreased larger than 30% from baseline; atropine 0.5 mg was used if heart rate was below 50 beats/minute.

All 136 patients were randomly divided into 3 groups by an anesthesiologist. A nurse anesthetist prepared medications. Two syringes were numbered as no 1 and 2. In the pregroup, no 1 syringe was filled with methylprednisolone 40 mg that was diluted by normal saline to 5 mL, and no 2 syringe was filled with normal saline at a volume of 5 mL. For the postgroup, no 1 syringe was filled with normal saline at a volume of 5 mL, and no 2 syringe was filled with methylprednisolone 40 mg that was diluted by normal saline to 5 mL. For the control group, both no 1 and 2 syringes were filled with normal saline at a volume of 5 mL. Half an hour before general anesthesia and immediately after the end of anesthesia induction and intubation, each patient was injected intravenously with no 1 and 2 syringes for 10 seconds. All researchers who monitored anesthesia and muscle relaxant were blinded to the patient groups.

Neuromuscular transmission was monitored by mechanomyography using quantitative neuromuscular transmission monitor (HXD-1, CO28; Heilongjiang Huaxiang Technology, Ltd, Harbin, China) on the arm opposite to the blood pressure cuff. After cleaning the skin with 75% alcohol, 2 electrodes were placed on the ulnar nerve in the wrist near the end. After asked to slightly clench the muscle tension sensor with a set preload of 250 g, medical tapes were fixed up. Train-of-four (TOF) stimulation was provided to ulnar nerve in a frequency of 0.1 Hz, square wave pulses of 0.25 ms, and string spacing of 12 seconds to closely monitor muscle twitch response within the adductor policies muscle. When patients were falling asleep, we started the research. After it became steady (<5% variations of the 1st twitch [T1] and the TOF ratio [TOFR] >2 minutes), electrical stimulation was switched on with a muscle twitch height calibrated to 100%. Rocuronium 0.6 mg/kg was administered intravenously within 5 seconds.

During the surgery, the following parameters that representing rocuronium's effects on muscle relaxation were closely monitored: onset time (time required for T1 drop to zero immediately after administration of rocuronium), clinical duration (time between administration of rocuronium and recovery to 25% twitch height of T1); total duration (time between administration of rocuronium and recovery to 95% twitch height of T1); and recovery index (T1 restored from 25% to 75%) and time required for restoring TOFR 90% (time between administration of rocuronium and T4/T1 = 90%).

Other information such as patient's age, height, weight, and length of surgery was also recorded.

According to our preliminary results involving 20 patients, for the control group, 70 minutes was required to restore TOFR to 90% (standard deviation [SD] as 7 minutes). Therefore, it was presumed that for the methylprednisolone group, in order to obtain a clinical significance, time required for TOFR 90% should be shortened for at least 5 minutes. Hence, in the level of α = 0.05 and β = 0.1, at least 36 patients were needed in each group. Considering the possibility of excluding patients, we then chose a total of 136 patients in our present study.

All data were analyzed by SPSS17.0 (SPSS, Inc., Chicago, IL). Continuous measurement data were expressed as means (SD). If data were normally distributed, comparison among the groups was performed by one-way analysis of variance (ANOVA). When the differences of average levels among 3 groups were statistically significant, multiple comparisons with Students–Newman–Keuls method will be carried out. P < .05 was considered statistically significant.

Back to Top | Article Outline

3 Results

Twenty-nine cases among 136 patients were excluded for various reasons, thus there were 107 patients completed the study (Fig. 1). No statistical difference was found in age, height, weight, body mass index, American Society of Anesthesiologists classification, and length of surgery among all the patients (Table 1).

Figure 1

Figure 1

Table 1

Table 1

All patients achieved a maximum effect of muscle relaxantion, and successfully completed intubation. Among the 3 groups, the onset time of muscle relaxants and recovery index had no significant difference. Compared to control group, pre-, and postgroups had significantly shorter clinical duration, total duration, and time required for TOFR 90% (P < .05); however, these parameters were not significantly different between pregroup and postgroup (Table 2).

Table 2

Table 2

Back to Top | Article Outline

4 Discussion

In the present study, we found that administration of methylprednisolone 40 mg, no matter half-hour before surgery or immediately after intubation, could shorten both clinical duration, total duration, and time required for TOFR 90% of rocuronium-induced blockade; however, the onset time and recovery index were not significantly different to that of the control group. It should be emphasized that the results of clinical duration and time required for restoring TOFR 90% were more important, for clinical duration told us whether we need additional muscle relaxant and time required for restoring TOFR 90% was used to evaluate muscle relaxation and extubation safety.

The interaction between glucocorticoids and neuromuscular blockade drugs has attracted great attention in recent years. On the one hand, nondepolarizing neuromuscular blockade drugs exert shorter duration of action on patients with long-term use of prednisone.[26] On the other hand, Carlson et al[27] had observed elevated cortisol levels in sepsis patients with abnormal neuromuscular system; in other words, glucocorticoids can affect the transmission of nerve muscle activity, thereby reducing the duration of action in nondepolarizing muscle relaxants. However, the mechanism of interaction between glucocorticoids and neuromuscular blockade drugs is still unknown, which may be related to the synthesis, release, and store of acetylcholine at the presynaptic neuromuscular junction, as promoted by glucocorticoids.[28,29] This hypothesis was reinforced by the glucocorticoid-mediated increase the frequency and quantal content of end-plate potentials and miniature end-plate potentials in the mouse isolated diaphragm.[30–32]

Although clinical doses of methylprednisolone range from 20 to 250 mg,[13,14,21,33,34] in some studies, it can be up to 10 mg/kg.[16] However, low-dose methylprednisolone had no difference to that of high-dose methylprednisolone, while it can significantly reduce the side effects of glucocorticoids.[35,36] In our clinical practice, 40 mg methylprednisolone was more preferentially used especially for treating patients who were mild to moderate allergic. Therefore, in the present study, a single dose of intravenous methylprednisolone 40 mg was chosen. In this study, a recommended dose of rocuronium for intubation, 0.6 mg/kg, was selected, thus all patients can achieve a maximum blockade effects of muscle relaxation in order to successfully complete intubation. The reason we choose the patients with laparoscopic gynecological surgery under general anesthesia was that this surgery has a low requirement for muscle relaxation; therefore, the experimental observations can be easily achieved.

It should be emphasized that we do not expect to reverse the muscle relaxant effects of methylprednisolone on rocuronium. We aimed to explore the impact of methylprednisolone, as a widely used perioperative drugs, on muscle relaxants. The results showed that administration of methylprednisolone before or during surgery may shorten the duration of action of rocuronium on muscle relaxation. Currently, neuromuscular monitoring is not a conventional item in a considerable number of hospitals. Thus, it should to be aware that during surgery, if methylprednisolone is being used due to antiinflammatory or prevention of PONV, its impact on muscle relaxation should be taken into account.

There are several limitations in our study design. First, all subjects in our study were female, thus, whether similar results can be obtained in male patients cannot be warranted. Currently, there is no study implying the participation of gender factors in the drug actions of methylprednisolone or nondepolarizing neuromuscular blockade drugs. Second, the present study used a single dose of methylprednisolone 40 mg, although this dose is being frequently used in clinical practice, perioperative surgery might need higher doses, even up to 10 mg/kg.[16] In addition, it is not clear that whether a dose-dependent effect of methylprednisolone on the duration of rocuronium exists, thus further study is needed to investigate whether higher doses of methylprednisolone could shorten the duration of action of muscle relaxants. Third, the subjects we chose are the patients undergoing laparoscopic gynecological surgery. However, Wang et al had suggested that for laparotomy, rocuronium had an extended duration of action in laparoscopic surgery.[37] Therefore, further study is needed to investigate whether our results are applicable to laparotomy.

In summary, our present study showed that a single intravenous injection of methylprednisolone 40 mg, no matter in the preoperative or intraoperative surgery, could shorten the duration of action of rocuronium.

Back to Top | Article Outline


[1]. Robinson BJ, Lee E, Rees D, et al. Betamethasone-induced resistance to neuromuscular blockade: a comparison of atracurium and vecuronium in vitro. Anesth Analg 1992;74:762–5.
[2]. Soltesz S, Mencke T, Stunz M, et al. Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone. Acta Anaesthesiol Scand 2009;53:443–8.
[3]. Capuano A, Sullo MG, Rafaniello C, et al. Complete resistance after maximal dose of rocuronium. J Pharmacol Pharmacother 2015;6:175–8.
[4]. Soltesz S, Fraisl P, Noe KG, et al. Dexamethasone decreases the duration of rocuronium-induced neuromuscular block. Eur J Anaesthesiol 2014;31:417–22.
[5]. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002;195:694–711.
[6]. Miller B. Postoperative nausea and vomiting. Anaesth Intens Care Med 2006;7:453–5.
[7]. Ustun Y, Erdogan O, Esen E, et al. Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:535–9.
[8]. Kizilkaya M, Yildirim OS, Dogan N, et al. Analgesic effects of intraarticular sufentanil and sufentanil plus methylprednisolone after arthroscopic knee surgery. Anesth Analg 2004;98:1062–5.
[9]. Romundstad L, Breivik H, Roald H, et al. Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo. Anesth Analg 2006;102:418–25.
[10]. Bigler D, Jonsson T, Olsen J, et al. The effect of preoperative methylprednisolone on pulmonary function and pain after lung operations. J Thorac Cardiovasc Surg 1996;112:142–5.
[11]. Nagelschmidt M, Fu ZX, Saad S, et al. Preoperative high dose methylprednisolone improves patients outcome after abdominal surgery. Eur J Surg 1999;165:971–8.
[12]. Kerr KM, Auger WR, Marsh JJ, et al. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest 2012;141:27–35.
[13]. François B, Bellissant E, Gissot V, et al. 12-Hour pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomized double-blind trial. Lancet 2007;369:1083–9.
[14]. Cheng KC, Hou CC, Huang HC, et al. Intravenous injection of methylprednisolone reduces the incidence of postextubation stridor in intensive care unit patients. Crit Care Med 2006;34:1345–50.
[15]. Keski-Nisula J, Pesonen E, Olkkola KT, et al. Methylprednisolone in neonatal cardiacsurgery: reduced inflammation without improved clinical outcome. Ann Thorac Surg 2013;95:2126–32.
[16]. Matsutani T, Onda M, Sasajima K, et al. Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res 1998;79:158–63.
[17]. Baigrie RJ, Lamont PM, Kwiatkowski D, et al. Systemic cytokine response after major surgery. Br J Surg 1992;79:757–60.
[18]. Miyashita M, Onda M, Sasajima K, et al. Humoral mediators in surgical stress and multiple organ failure. 3rd International Congress on the Immune Consequences of Trauma, Shock and Sepsis – Mechanisms and Therapeutic Approaches,Munich, Germany,March 2–5,1994,pp256–61.
[19]. Kambayashi J, Sakon M, Yokota M, et al. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers. Thromb Res 1990;60:157–67.
[20]. Tsuji K, Eguchi Y, Kodama M. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Am Coll Surg 1996;183:230–8.
[21]. Shimada H, Ochiai T, Okazumi S, et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 2000;128:791–8.
[22]. Czarnetzki C, Lysakowski C, Elia N, et al. Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate:a randomized study. Acta Anaesthesiol Scand 2010;54:299–306.
[23]. Kussman B, Shorten G, Uppington J, et al. Administration of magnesium sulphate before rocuronium: effects on speed of on- set and duration of neuromuscular block. Br J Anaesth 1997;79:122–4.
[24]. Kim SH, So KY, Jung KT. Effect of magnesium sulfate pretreatment on onset and recovery characteristics of cisatracurium. Korean J Anesthesiol 2012;62:518–23.
[25]. Sokoll MD, Gergis SD. Antibiotics and neuromuscular function. Anesthesiology 1981;55:148–59.
[26]. Soltész S, Mencke T, Mey C, et al. Influence of a continuous prednisolone medication on the time course of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease. Br J Anaesth 2008;100:798–802.
[27]. Carlson GL, Saeed M, Little RA, et al. Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am J Physiol 1999;276(4 Pt 1):658–62.
[28]. Veldsema-Currie RD, Wolters E, Leeuwin RS. The effect of corticosteroids and hemicholinium-3 on choline uptake and incorporation into acetylcholine in rat diaphragm. Eur J Pharmacol 1976;35:399–402.
[29]. Dal Belo CA, Leite GB, Fontana MD, et al. New evidence for a presynaptic action of prednisolone at neuromuscular junctions. Muscle Nerve 2002;26:37–43.
[30]. Dalkara T, Onur R. Facilitatory effects of dexamethasone on neuromuscular transmission. Exp Neurol 1987;95:116–25.
[31]. Engel WK, Warmolts JR. Myasthenia gravis: a new hypothesis of the pathogenesis and a new form of treatment. Ann NY Acad Sci 1971;183:72–87.
[32]. Leeuwin RS, Veldesema-Currie RD, Van Wilgenburg H, et al. Effects of corticosteroids on neuromuscular blocking actions of d-tubocurarine. Eur J Pharmacol 1981;69:165–73.
[33]. Flood TR, McManners J, el-Attar A, et al. Randomized prospective study of the influence of steroids on postoperative eye-opening after exploration of the orbital floor. Br J Oral Maxillofac Surg 1999;37:312–5.
[34]. Koçer G, Yuce E, Tuzuner Oncul A, et al. Effect of the route of administration of methylprednisolone on oedema and trismus in impacted lower third molar surgery. Int J Oral Maxillofac Surg 2014;43:639–43.
[35]. Whitlock RP, Young E, Noora J, et al. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I. J Surg Res 2006;132:188–94.
[36]. Sauerland S, Nagelschmidt M, Mallmann P, et al. Risks and benefits of preoperative high dose methylprednisolone in surgical patients. Drug Saf 2000;23:449–61.
[37]. Wang T, Huang S, Geng G. Comparison of the duration of neuromuscular blockade following a single bolus dose of rocuronium during laparoscopic gynaecological surgery vs conventional open surgery. Anaesthesia 2014;69:854–9.

intraoperative; methylprednisolone; rocuronium-induced neuromuscular blockade

Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.